FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
Medway NHS Foundation Trust, one of the largest and most innovative NHS trusts in the South-East of England, has taken a bold step forward in its virtual care journey by transitioning to a new digital platform – part of its…
Chancellor Rachel Reeves announced that the government is investing up to £10bn to bring the NHS “into the digital age” as part of the latest spending review.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us